[1]
Małek, M. et al. 2026. Glucagon-like peptide-1 receptor agonists in metabolic dysfunction-associated steatotic liver disease: a narrative review. Quality in Sport. 60, (Jun. 2026), 72834. DOI:https://doi.org/10.12775/QS.2026.60.72834.